AstraZeneca partners with Cambridge Institute for Sustainability Leadership to launch unique sustainability project in Kenya

Today at the 71stWorld Health Assembly, AstraZeneca will announce a new sustainability project in partnership with the Cambridge Institute for Sustainability Leadership (CISL). The pilot will see the introduction of portable biodigesters to Dunga Beach on Lake Victoria in Kenya, which will allow the local community to process organic waste into valuable clean energy. It will study the impact on the environment and local economy, and provide potential insight into the effect of clean cooking on respiratory health.

The project will use an innovative local technology supplied by a Kenyan firm, Biogas International Ltd, and will see the launch of 50 domestic-scale flexi-biogas plants and two community scale plants in October 2018 in Dunga Beach.

The process involves feeding waste materials together with water hyacinth – a local weed known to clog the lake at Dunga Beach – into digesters that generate cooking gas and fertiliser that is cleaner and greener than current alternatives.

Each digester will provide enough energy to meet the needs of a typical home for a day, while the larger community systems will provide cooking services and charging for local fishermen, fish processors and market stalls. The biogas itself can be used for a variety of purposes from fuelling cooking equipment to incubating chicks and purifying water.

The project aims to improve respiratory health in the community by reducing exposure to smoke from cooking over wood-burning fires. It will also reduce the time taken by villagers, particularly women and children, to collect firewood for cooking, allowing them to invest it in, for example, schooling or income-generating activities.

Additionally, the move from firewood to gas is expected to have an impact on the local environment, supporting the Kenyan Government’s target to increase the country’s tree cover from the current 6.2 per cent to 10 per cent.

AstraZeneca is working to continue connecting its industry-leading environmental work to improving patient health. An opportunity identified through AstraZeneca’s well-established Healthy Heart Africa programme, this pilot will explore how technology can deliver health benefits in tandem with multiple social, economic and environment gains.

“This initiative is another example of a strategic collaboration between AstraZeneca, with global headquarters in Cambridge, and the University of Cambridge”, commented Katarina Ageborg, EVP Sustainability and Chief Compliance Officer at AstraZeneca. “The project embodies our sustainability agenda and is unique in the way it allows us to leverage our strengths in access, science and innovation to provide a package that will ultimately benefit a local community. We look forward to working closely with our partners and the local community at Dunga Beach over the coming months to get the pilot programme up and running in the autumn.”

Dr Jake Reynolds, Executive Director at the Cambridge Institute for Sustainability Leadership added, “The pilot explores how a simple sustainability technology – locally generated biogas – can improve health and economic outcomes in a rural location in Kenya. The arrival of a clean, green cooking fuel, produced from organic materials on the doorstep, will eliminate both the toxic smoke arising from wood-fired kitchens and the daily burden of firewood collection which falls largely on women. Cambridge and AstraZeneca share an interest in the science and practice of preventative health, and by partnering we hope to create unique – and sharable – insights into positive development solutions in sub-Saharan Africa.”

About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

For more information, please visit and follow us on Twitter @AstraZeneca.

About the Cambridge Institute for Sustainability Leadership

CISL is a globally influential institute within in the University of Cambridge, working with leaders to build a sustainable economy. Through focused collaboration between business, government and finance institutions, we believe the economy can be ‘rewired’ to deliver positive outcomes for people and the environment – in short to deliver the UN Sustainable Development Goals. For more information, please visit and follow us on Twitter @cisl_cambridge.



  • Sustainability